IDEXX raises forecast, betting diagnostics can offset weak vet visits

By Sahil Pandey Nov 2 (Reuters) – IDEXX Laboratories beat quarterly estimates and raised its annual profit and revenue forecast on Monday, betting that rising diagnostic use per visit and new product launches will sustain growth through softer veterinary clinic traffic. Shares of the pet diagnostics maker climbed more than 19% in morning trading. The results come as animal-health companies…

Open True Mainstream to compare left, right, and center coverage

1,600+ newsrooms tracked, in English, around the clock. Real newsrooms only — no NGOs, no press releases. Left/Right tags come from reader feedback. No algorithmic feed.